NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank93
3Y CAGR-9.2%
5Y CAGR+5.8%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-9.2%/yr
vs +46.0%/yr prior
5Y CAGR
+5.8%/yr
Recent deceleration
Acceleration
-55.1pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$5.20M+4.4%
2025$4.98M-1.6%
2024$5.07M-27.0%
2023$6.94M+40.8%
2022$4.93M+25.6%
2021$3.93M+89.1%
2020$2.08M+35.7%
2019$1.53M+60.8%
2018$951064.00+29.3%
2017$735333.00-